Toxigenic cutaneous diphtheria is a notifiable disease that is re-emerging in the world and particularly in France. A better description of the epidemiological characteristics, as well as a refinement of the clinical characteristics of patients with cutaneous diphtheria, are essential to better understand this pathology, which has important public health issues and whose diagnosis absence can have catastrophic consequences for the patient and their contacts. Microbiological data (species identification, toxigenicity or not, resistance profile...) will be transmitted by the national reference center for corynebacteria of the diphtheriae complex and then caregivers who have managed the corresponding patients with cutaneous diphtheria will be contacted.
Study Type
OBSERVATIONAL
Enrollment
63
Caregivers who follow the patients of the study group will be contacted to collect these patients clinical and epidemiological characteristics
Institut Hospitalo-Universitaire de Marseille
Marseille, Bouches-du-Rhône, France
CHU de Dijon
Dijon, Bourgogne-Franche-Comté, France
CHU de Caen
Caen, Calvados, France
Centre Hospitalier de Brive
Brive-la-Gaillarde, Corrèze, France
Centre Hospitalier de Guingamp
Pabu, Côtes d'Armor, France
Patients epidemiological data description
Epidemiological data will be collected to describe the studied population (age, sex, place of birth, vaccination status...)
Time frame: 3 months
Patients clinical data description
Clinical data will be collected to describe the studied population (history, description of lesions, disease evolution, complications...)
Time frame: 3 months
Patients microbiological data description
Microbiological data will be collected to describe the studied population (species identification, toxigenicity, presence of a co-infection...)
Time frame: 3 months
Patients therapeutic data description
Therapeutic data will be collected to describe the studied population (antibiotic therapy, duration of treatment, search for an eradication a posteriori...)
Time frame: 3 months
Comparison of antibiotic therapy duration to national recommendations issued by the High Committee of Public Health
Duration of antibiotic therapy implemented by clinicians will be compared to national recommendations
Time frame: 3 months
Comparison of immunization status monitoring to national recommendations issued by the High Committee of Public Health
Monitoring of immunization status or not will be collected
Time frame: 3 months
Comparison of patient post infection vaccination status to national recommendations issued by the High Committee of Public Health
Post-infection vaccination or not will be collected
Time frame: 3 months
Comparison of patient microbiological follow-up to national recommendations issued by the High Committee of Public Health
Microbiological follow-up with eradication research or not will be collected.
Time frame: 3 months
Comparison of post-infection serological sampling to national recommendations issued by the High Committee of Public Health
Whether a post-infection serological sampling was performed or not will be collected.
Time frame: 3 months
Comparison of patient isolation procedures to national recommendations issued by the High Committee of Public Health
Patient isolation or not will be collected.
Time frame: 3 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Centre Hospitalier Sud Francilien
Corbeil-Essonnes, Essonne, France
CHU Bordeaux
Bordeaux, Gironde, France
Hôpital Louis Pasteur (HCC)
Colmar, Haut-Rhin, France
Centre Hospitalier Alpes-Leman CHAL
Contamine-sur-Arve, Haute-Savoie, France
Centre Hospitalier de Briançon
Briançon, Hautes-Alpes, France
...and 32 more locations